Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion type Assertion NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_head.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion description "[Pharmacological treatment of Rh1(P37H) flies with the VCP/ERAD inhibitor Eeyarestatin I or with the proteasome inhibitor MG132 also led to a strong suppression of retinal degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_provenance.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion evidence source_evidence_literature NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_provenance.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion SIO_000772 20865169 NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_provenance.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion wasDerivedFrom befree-20140225 NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_provenance.
- NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_assertion wasGeneratedBy ECO_0000203 NP505283.RA0yeIwcxWQ8BBLkLrFT6nmdJhdN-54mvzqZa-zRx8yus130_provenance.